NO921831L - Indolderivater, fremgangsmaate for fremstilling derav samtpreparater inneholdende et slikt derivat - Google Patents
Indolderivater, fremgangsmaate for fremstilling derav samtpreparater inneholdende et slikt derivatInfo
- Publication number
- NO921831L NO921831L NO92921831A NO921831A NO921831L NO 921831 L NO921831 L NO 921831L NO 92921831 A NO92921831 A NO 92921831A NO 921831 A NO921831 A NO 921831A NO 921831 L NO921831 L NO 921831L
- Authority
- NO
- Norway
- Prior art keywords
- atoms
- consumptions
- derivative
- procedures
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4115215A DE4115215A1 (de) | 1991-05-10 | 1991-05-10 | Indolderivate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO921831D0 NO921831D0 (no) | 1992-05-08 |
| NO921831L true NO921831L (no) | 1992-11-11 |
Family
ID=6431344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO92921831A NO921831L (no) | 1991-05-10 | 1992-05-08 | Indolderivater, fremgangsmaate for fremstilling derav samtpreparater inneholdende et slikt derivat |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0512350A3 (enExample) |
| JP (1) | JPH05155886A (enExample) |
| KR (1) | KR920021507A (enExample) |
| AU (1) | AU1604492A (enExample) |
| CA (1) | CA2068238A1 (enExample) |
| CS (1) | CS130592A3 (enExample) |
| DE (1) | DE4115215A1 (enExample) |
| HU (1) | HU208136B (enExample) |
| IE (1) | IE921488A1 (enExample) |
| MX (1) | MX9202152A (enExample) |
| NO (1) | NO921831L (enExample) |
| PL (1) | PL294457A2 (enExample) |
| TW (1) | TW221807B (enExample) |
| ZA (1) | ZA923351B (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69111816T4 (de) * | 1990-08-31 | 1996-08-01 | Nippon Shinyaku Co Ltd | Indolederivate und ihre verwendung als serotonin-antagoniste. |
| IT1255467B (it) * | 1992-07-29 | 1995-11-02 | Dompe Farmaceutici Spa | Ammidi acriliche farmacologicamente attive |
| US6492385B2 (en) | 2000-08-18 | 2002-12-10 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease |
| AU2001282874A1 (en) | 2000-08-18 | 2002-03-04 | Pharmacia And Upjohn Company | Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands) |
| US6486172B2 (en) | 2000-08-18 | 2002-11-26 | Pharmacia & Upjohn Company | Quinuclidine-substituted aryl compounds for treatment of disease |
| WO2002017358A2 (en) | 2000-08-21 | 2002-02-28 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists) |
| WO2002015662A2 (en) | 2000-08-21 | 2002-02-28 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists |
| DE10045112A1 (de) * | 2000-09-11 | 2002-03-21 | Merck Patent Gmbh | Verwendung von Indolderivaten zur Behandlung von Erkrankungen des zentralen Nervensystems |
| AR036041A1 (es) | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen |
| AR036040A1 (es) | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen |
| CZ2004408A3 (cs) | 2001-10-02 | 2005-03-16 | Pharmacia & Upjohn Company | Azabicyklicky substituované kondenzované heteroarylsloučeniny |
| US6849620B2 (en) | 2001-10-26 | 2005-02-01 | Pfizer Inc | N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease |
| DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
| CA2476624A1 (en) | 2002-02-19 | 2003-08-28 | Pharmacia & Upjohn Company | Azabicyclic compounds for the treatment of disease |
| JP2005523288A (ja) | 2002-02-19 | 2005-08-04 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 疾病治療用の縮合した二環式−ｎ−架橋−複素環式芳香族カルボキサミド |
| WO2004013137A1 (en) | 2002-08-01 | 2004-02-12 | Pharmacia & Upjohn Company Llc | 1h-pyrazole and 1h-pyrrole-azabicyclic compounds with alfa-7 nachr activity |
| WO2009158375A1 (en) * | 2008-06-25 | 2009-12-30 | Abbott Laboratories | Aza-cylic indole- 2 -carboxamides and methods of use thereof |
| HUE026815T2 (en) | 2008-11-19 | 2016-07-28 | Forum Pharmaceuticals Inc | Treatment of Cognitive Disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof |
| TWI519532B (zh) | 2010-05-17 | 2016-02-01 | 艾維沃製藥公司 | （Ｒ）－７－氯－Ｎ－（啶－３－基）苯並［b］噻吩－２－羧醯胺鹽酸鹽單水合物之結晶形體 |
| RU2017136693A (ru) | 2012-05-08 | 2019-02-08 | Форум Фармасьютикалз, Инк. | Способы поддержания, лечения или улучшения когнитивной функции |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU202108B (en) * | 1986-07-30 | 1991-02-28 | Sandoz Ag | Process for producing pharmaceutical compositions containing serotonine antqgonistic derivatives of indol-carboxylic acid or imidazolyl-methyl-carbazol |
| DE3881950T2 (de) * | 1987-04-25 | 1993-09-30 | Beecham Group Plc | Azabicyclische Verbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen. |
| NZ227841A (en) * | 1988-02-12 | 1991-08-27 | Merck Sharp & Dohme | Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions |
| DE3810552A1 (de) * | 1988-03-29 | 1989-10-19 | Sandoz Ag | Ester und amide von indol-, benzo(b)thiopen-, benzo(b)furancarbonsaeuren oder 4-amino-2-methoxy-benzolsaeuren mit n-heterocyclischen oder n-heterobicyclischen alkoholen oder aminen, verfahren zu deren herstellung sie enthaltende pharmazeutische zusammensetzungen sowie applikator zur verabreichung derselben |
-
1991
- 1991-05-10 DE DE4115215A patent/DE4115215A1/de not_active Withdrawn
-
1992
- 1992-04-27 EP EP19920107132 patent/EP0512350A3/de not_active Withdrawn
- 1992-04-29 CS CS921305A patent/CS130592A3/cs unknown
- 1992-05-05 AU AU16044/92A patent/AU1604492A/en not_active Abandoned
- 1992-05-07 PL PL29445792A patent/PL294457A2/xx unknown
- 1992-05-07 TW TW081103571A patent/TW221807B/zh active
- 1992-05-08 KR KR1019920007824A patent/KR920021507A/ko not_active Withdrawn
- 1992-05-08 MX MX9202152A patent/MX9202152A/es unknown
- 1992-05-08 NO NO92921831A patent/NO921831L/no unknown
- 1992-05-08 ZA ZA923351A patent/ZA923351B/xx unknown
- 1992-05-08 HU HU9201550A patent/HU208136B/hu not_active IP Right Cessation
- 1992-05-08 CA CA002068238A patent/CA2068238A1/en not_active Abandoned
- 1992-05-11 JP JP4143642A patent/JPH05155886A/ja active Pending
- 1992-07-01 IE IE148892A patent/IE921488A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUT61541A (en) | 1993-01-28 |
| KR920021507A (ko) | 1992-12-18 |
| CA2068238A1 (en) | 1992-11-11 |
| PL294457A2 (en) | 1992-11-16 |
| HU9201550D0 (en) | 1992-07-28 |
| IE921488A1 (en) | 1992-11-18 |
| EP0512350A2 (de) | 1992-11-11 |
| CS130592A3 (en) | 1992-11-18 |
| NO921831D0 (no) | 1992-05-08 |
| MX9202152A (es) | 1992-11-01 |
| HU208136B (en) | 1993-08-30 |
| DE4115215A1 (de) | 1992-11-12 |
| ZA923351B (en) | 1993-01-27 |
| TW221807B (enExample) | 1994-03-21 |
| AU1604492A (en) | 1992-11-12 |
| EP0512350A3 (en) | 1992-12-16 |
| JPH05155886A (ja) | 1993-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1264828E (pt) | Inibidor de uroquinase | |
| NO20050648L (no) | Heterocyklisk substituerte benzoylureaer, fremgangsmate for fremstilling derav og deres anvendelse som medikamenter | |
| NO20062136L (no) | Imidazopyrazintyrosin-kinaseinhibitorer | |
| NO20052805L (no) | Substituerte pyrrolo-pyrazolderivater som kinase-inhibitorer | |
| NO870241L (no) | Hypoglykemiske tiazolidindioner. | |
| EA200400305A1 (ru) | 2,4,5-тризамещенные производные тиазолила и их противовоспалительная активность | |
| DE69017606D1 (de) | Substituierte Cyclohexanole mit zentraler Nervensystemwirkung. | |
| NO962543L (no) | Cykliske amid-derivater som neurokinin A-antagonister | |
| YU97292A (sh) | N-fenilalanil i n-fenilglicil derivati dipeptida l-azetidin-2-karboksilne kiseline | |
| BR0313407A (pt) | Novo uso de derivados de benzotiazol | |
| NO20014363D0 (no) | 4-okso-4,7-dihydro-tieno[2,3-b]pyridin-5-karboksamider som antivirale midler | |
| NO963731L (no) | Behandling av obsessive-kompulsive sykdommer med 5HT2-antagonister | |
| DK1747220T3 (da) | Substituerede 1H-pyrrolo[3,2-B, 3,2-C og 2,3-C]pyridin-2-carboxamider og relaterede analoger som inhibitorer af casein kinase I epsilon | |
| EA200400208A1 (ru) | Фенилацетамидотиазольные производные, способ их получения и их использования в качестве противоопухолевых средств | |
| KR920021507A (ko) | 인돌 유도체 | |
| WO2007099302A3 (en) | Methods of maintaining oral health in animals using morpholine derivatives | |
| ATE194338T1 (de) | Diphenylthiazolderivate mit antiinflammatorischer aktivität | |
| BR0306148A (pt) | Compostos, composições farmacêuticas, e, uso de um composto | |
| AU1316892A (en) | Use of 4-amino-1-(2-pyridyl)piperidines for the preparation of a medicament for the treatment and prophylaxis of conditions deriving from disorders of the serotoninergic systems mediated by 5-ht3 receptors | |
| NO982863L (no) | Nye forbindelser med analgetisk effekt | |
| NO905254L (no) | Fremgangsmaate for fremstilling av substituerte cykloheksener. | |
| FR2539415B1 (fr) | Derives de la d-2 imidazoline, leur preparation et leur application en therapeutique | |
| NO20051471L (no) | Piperidin-2,6-dionpamoatsalter og deres anvendelse for behandling av stressrelaterte affektforstyrrelser | |
| NO996244L (no) | Pyrrolidinkarboksylsyrederivater som endotelinantagonister | |
| NO984007L (no) | Nye disubstituerte trans-3,4,4a,5,6,10b-heksahydro-2H-naft[1,2-b]-1,4-oksaziner, en fremgangsmÕte ved deres fremstilling og farmas°ytiske sammensetninger inneholder disse |